Recruiting and retaining an adequate sample is critical to the success of any research project involving humans. Recent reports indicate that the Health Insurance Portability and Accountability Act (HIPAA) privacy rule has adversely affected research. Few resources are available to help researchers navigate the challenges to recruitment and retention after HIPAA privacy rule implementation. This article addresses obstacles to recruitment in prospective clinical research studies related to the HIPAA privacy rule, as well as HIPAAcompliant strategies to enhance recruitment and retention. Recruitment challenges discussed include evolving interpretations of the HIPAA regulations, inability to directly contact potential participants, complexity of HIPAArequired documents, increased costs of recruitment, and an expanding administrative burden. Among the strategies addressed are preparatory research reviews, using clinical collaborators and staff liaisons, prescreening potential participants, minimizing participant burden during the consent process, enhancing participant follow-up, facilitating recruitment for future studies, and streamlining compliance training for staff.
R ecruitment and retention of research participants is challenging at best. At its worst, recruitment can be a nightmare. The proverbial disappearing sample is an all-too-common phenomenon experienced by many human participants researchers (Wilson-Barnett & Griffiths, 2002) . A number of researchers have examined the challenges of participant recruitment and retention in specific patient populations across a number of different settings (Blanton et al., 2006; Heiney et al., 2006; Im & Chee, 2005; Loftin, Barnett, Bunn, & Sullivan, 2005; Northouse et al., 2006; Rose, 2000; Villarruel, Jemmott, Jemmott, & Eakin, 2006) . Most of the recent work in this area includes little information regarding the Health Insurance Portability and Accountability Act (HIPAA) privacy rule.
The HIPAA privacy rule became effective in April 2003. Although the original intent of HIPAA had nothing to do with research, by the time that the regulations were enacted, they affected research directly. In the wake of the implementation of the HIPAA privacy rule, researchers have begun to document that HIPAA is hindering research by increasing researchers' administrative burden (Clause, Triller, Bornhorst, Hamilton, & Cosler, 2004; Lydon-Rochelle & Holt, 2004) , delaying initial project approval (Heiney et al., 2006; O'Herrin, Fost, & Kudsk, 2004) , impeding participant recruitment processes (Albert & Levine, 2005; Blanton et al., 2006; Heiney et al.; Kaiser, 2004; Ness, 2005; Wolf & Bennett, 2006) , escalating recruitment costs (Albert & Levine; Heiney et al.) , hampering medical record and registry research (Inglefinger & Drazen, 2004; Lydon-Rochelle & Holt; O'Herrin et al.) , and generating data sets that are less than adequate for good research (Clause et al.; Inglefinger & Drazen; Maas, Kompanje, & Stocchetti, 2005) .
The purpose of the article is not to discuss the impact of HIPAA on research per se but rather to address the impact of HIPAA on participant recruitment and retention issues in prospective clinical research studies. Proactive HIPAA compliant strategies for participant recruitment and retention are emphasized. Because the interpretation of the HIPAA privacy rule continues to vary widely, often depending on the local level of risk avoidance of the institutional review board (IRB) or privacy board (Albert & Levine, 2005; Ness, 2005) , researchers should consult with their institutions' IRB or privacy board policies to ensure local compliance.
The impact of HIPAA on participant recruitment and retention can be broken down into seven basic areas: preparatory research, initial contact of potential participants, prescreening potential participants, consenting participants, long-term follow-up of participants, recruitment for future studies, and training of research staff. Administrative burden is addressed as it pertains to these areas.
Preparatory Research
In planning a study and preparing a grant application, it is essential to know the potential study population available for recruitment. An accurate estimate of the percentage of participants available who will meet the study's inclusion criteria also is necessary. When planning an intervention study, it is quite useful to know what the current standard of care is at each institution. This type of information can be obtained via chart review at potential recruitment sites. Before HIPAA, these activities were not regulated by the IRB. Under HIPAA, accessing individually identifiable protected health information (PHI) for these purposes requires IRB or privacy board approval (Erlen, 2005; Olsen, 2003) . Some institutions initially interpreted HIPAA regulations to mean that a researcher could not access any medical records for preparatory research or recruitment without patient consent (Ness, 2005; Russell, 2004b) . These restrictions resulted in a significant barrier to participant recruitment. As institutions have become more familiar with the privacy rule, initial interpretations have been altered to allow HIPAA waivers and preparatory research reviews (Ness; Russell, 2004a) .
The purpose of preparatory research is to review PHI to prepare a research protocol or to facilitate participant recruitment by identifying prospective research participants for purposes of seeking their authorization to use or disclose PHI for a research study (U.S. Department of Health and Human Services, 2004) . Before performing preparatory research, the researcher completes a Preparatory to Research form and submits it to his or her local IRB or privacy board. On the form, the researcher outlines the following: the purpose of the review, what PHI will be used or disclosed, why the PHI is necessary for the research, where the information is located, and how and by whom the information will be accessed. The researcher agrees not to remove any PHI from the covered entity and to follow the minimum necessary standard. The minimum necessary standard requires the researcher to use only the information necessary to answer the questions outlined on his or her form (Muhlbaier, 2002) . For example, the researcher should examine records only for the approved clinics or health care providers and should not review information unrelated to his or her research topic. If no treatment relationship exists between the researcher and prospective participants, the researcher should work with hospital or clinic staff to contact potential research participants identified in the preparatory research.
A covered entity may require the individual who accesses medical records for preparatory research or recruitment to be an employee of the covered entity. If the researcher is not an employee, a co-investigator who is an employee of the covered entity can perform the review. In instances where all the investigator needs is the number of cases of a particular ICD-9 code (i.e., International Classification of Diseases, ninth revision; or insurance codes used to describe a medical diagnosis), the medical records department or clinic staff may be able to perform an electronic review for the researcher. Researchers need to be aware that some covered or hybrid entities may charge a fee for the generation of de-identified data (Gunn et al., 2004; Olsen, 2003) , or a medical record pull fee (see Lydon-Rochelle & Holt, 2004) .
Initial Contact of Participants
Gaining access to potential research participants with particular health conditions is a challenge for nurse researchers (Rose, 2000; Wilson-Barnett & Griffiths, 2002) , but the HIPAA regulations have made the initial contact of potential research participants more complicated. Before HIPAA, many researchers reviewed daily patient lists with clinic or hospital staff to identify potential eligible participants, and then they approached patients directly (Muhlbaier, 2002; Ness, 2005; Wolf & Bennett, 2006) . Under HIPAA, it is considered inappropriate for personnel at the covered or hybrid entity to disclose the names or contact information of potential participants to a researcher without the participants' explicit authorization. In other words, the researcher cannot obtain a list of clinic or hospital patients and directly approach them in person, over the telephone, or by sending out letters. Unless a HIPAA waiver can be obtained, a health care provider should introduce the study to the patient and obtain the patient's assent before the researcher may approach the potential participant.
As a result, some researchers have described substantial decreases in participant accrual, as well as increases in recruitment costs, after the implementation of the HIPAA privacy rule. Ness (2005) reported that recruitment of pregnant women for a preeclampsia prevention project decreased from an average of 12.4 participants per week before HIPAA to 5.7 participants per week after HIPAA. In the Selenium and Vitamin E Cancer Prevention Trial, researchers found that participant recruitment declined from 7.0 participants per week to 1.9 participants per week after HIPAA (Wolf & Bennett, 2006) . Wolf and Bennett also determined that recruitment costs increased from $49 per participant to $169 per participant after the implementation of the HIPAA privacy rule. Increased recruitment costs have been particularly problematic for studies already in progress at the time of the implementation of the HIPAA privacy rule.
In response to the HIPAA privacy rule, researchers have found it helpful to have one or more clinical collaborators or staff liaisons to facilitate participant recruitment. The most direct way that the clinical collaborator or staff liaison can assist the researcher with participant recruitment is to personally inform the patients about the study during a clinic or hospital visit. Although a patient is more likely to participate in a study if asked by his or her primary care provider or physician (Loftin et al., 2005) , having a physician or other clinic or hospital staff member determine study eligibility and introduce the study to potential participants may be challenging given the patient care responsibilities in a busy clinic or hospital unit. In fact, researchers have indicated that the more work required of physicians, the greater the resistance to assist with a study (Heiney et al., 2006) . A number of challenges to and strategies for obtaining gatekeeper buy-in have been identified by others (Northouse et al., 2006; Rose, 2000; Villarruel, Jemmott, Jemmott, & Eakin, 2006) . To facilitate patient referral in the post-HIPAA era, Wolf and Bennett (2006) found the following strategies helpful: add the clinic medical director as study key personnel; involve desk clerks, nurses, and physicians in patient referral; make sure that research staff is visible to the clinic staff; have research staff attend the clinic daily; and have the researcher visit the clinic frequently to encourage patient referral.
If research staff cannot be available on a daily basis for participant referral, an alternative strategy is to have the clinical collaborator or staff liaison obtain authorization from the patient to give the researcher the patient's contact information. In a recent National Institute of Nursing Research-funded study examining a smoking cessation intervention during pregnancy (grant title: "Nursing Smoking Cessation Intervention During Pregnancy"; years funded: 2001-2006; principal investigator: Linda Bullock, RN, PhD), the researcher recruited participants from Women, Infant, and Children (WIC) clinics at rural health departments in the Midwest. Pregnant women who visited the WIC clinic were informed of the study by the clinic staff. Interested patients signed a form allowing their contact information to be given to the researcher. The clinic placed a copy of the form in the patient's chart so that women were not asked more than once about participating in the study. After the researcher received the contact information, the patient was contacted via telephone by the research staff. This strategy allowed the researcher to recruit from multiple WIC clinics simultaneously while remaining HIPAA compliant.
An additional strategy is to have the clinical collaborator write a letter to the patients with the particular health condition of interest, informing them of the study. To facilitate the process, the researcher can draft a letter that the clinician can place on his or her letterhead. To prevent the impression that the clinician revealed patients' PHI to the researcher, the letter should be signed by the clinician only and then mailed by the clinician's administrative staff (Olsen, 2003) . Depending exclusively on a letter from clinical collaborators for recruitment has been criticized because it acts as an impersonal means of approaching potential participants, generates a biased sample, and lengthens the recruitment process (Albert & Levine, 2005; Kaiser, 2004; Rose, 2000) . Sample bias can be minimized and recruitment success increased by utilizing multiple methods of participant recruitment.
In addition to clinical collaborator referral, a number of other HIPAAcompliant strategies remain available to researchers (see Table 1 ). With prior approval of the local IRB, the use of flyers, advertisements, and the electronic media is an acceptable method for making initial contact with participants. For researchers with limited recruitment budgets, flyers and electronic media tend to be less expensive methods when compared to newspaper, magazine, radio, or television advertisements (Loftin et al., 2005) . Flyers can be posted at health care institutions such as hospitals and clinics, as well as in community locations such as pharmacies, public libraries, and senior and community centers. Many academic health sciences centers have a Web page advertising current clinical trials, and nurse researchers can request to have their projects posted on the Web page (see example at https://apps.muhealth.org/clinical_research/). Researchers who are faculty members at a school of nursing can utilize their school's Web page to advertise their projects (see example at http://www.missouri.edu/%7Efinfgeldd/). Web page advertisements can be designed to include contact information for the study coordinator, or they can have a study interest or sign-up form embedded on the Web page, which is sent to the researcher or Web master upon completion (see "Clinical Trials Sign Up Form" on https://apps.muhealth .org/clinical_research/).
With institutional approval, electronic advertisements can be sent out via e-mail to faculty, staff, and students. In our recent American Heart Associationfunded study examining the skin microvascular responses to compression bandaging and leg elevation in healthy young and older adults, we found that younger men (aged 20 to 30 years) were particularly responsive to electronic advertisements, whereas our midlife and older adults were more likely to have seen a flyer in the community or heard about the study from a friend. Our experience is consistent with reports from the Pew Internet and American Life Project indicating that the demographic characteristics of Internet users tend to be young, male, White, educated, and from a high socioeconomic status (Lenhart, Horrigon, & Fallows, 2004) . When advertisements and flyers are a major mode of recruitment, researchers must keep their research office telephones staffed every day, respond as quickly as possible to all inquiries, and anticipate that a high portion of the calls will be from individuals who do not meet study criteria (Heiney et al., 2006; Loftin et al., 2005) .
Prescreening Potential Participants
When flyers, advertisements, and snowball recruitment (i.e., current research participants are asked to refer other people who meet study criteria) are utilized, the first contact that the researcher has with the participant is over the telephone. Because at this point the researcher would be collecting PHI without a signed HIPAA authorization, some institutions had initially interpreted HIPAA regulations to mean that prescreening of potential participants over the telephone could no longer occur. This interpretation decreased recruitment efficiency because researchers were spending time scheduling and consenting potential participants only to find at the first study visit that the participant did not meet study criteria.
A researcher can prescreen potential participants over the telephone with the use of a HIPAA waiver of authorization. The researcher completes a HIPAA Waiver or Alteration of Authorization form and submits it to the local IRB or privacy board. On the form, the researcher describes the project, the PHI to be collected, and sources of the PHI and agrees to adhere to the minimum necessary standard. The researcher needs to demonstrate the following: that the research could not practicably be done without a waiver (or alteration); that the research could not practicably be done without PHI;
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Table 1 Health Insurance Portability and Accountability Act Compliant Strategies for Initial Participant Contact
Advertisements in newspapers, the radio, and television Physician, advanced practice nurse, and clinic staff referral Electronic media advertisements Flyers and pamphlets in clinics and surrounding community Presentation at churches and advertisement in church bulletin Presentation at support group and advertisement in newsletter Presentation at community or senior center Recruitment booth at local health and wellness fairs Snowball/reactive recruitment that the participants' rights and welfare will not be adversely affected; that there is a reasonable risk-to-benefit ratio; that the use or disclosure plan involves no more than minimal risk to privacy; and that a plan is in place to protect identifiers and destroy identifiers at the earliest opportunity (U.S. Department of Health and Human Services, 2004). The researcher agrees to destroy all the data collected if the participant fails the telephone screening or is not interested in participating. For privacy purposes, the data collected should be disposed of by shredding. If the participant passes the telephone prescreening and desires to participate, the researcher obtains informed consent and a HIPAA authorization from the participant as soon as possible (i.e., during the first study visit).
Alternatively, some institutions may determine that a HIPAA Waiver or Alteration of Authorization is not required if a potential participant calls the recruitment number and is screened at that time, because the person is freely volunteering to provide his or her health information. As previously mentioned, consultation with the researcher's local IRB or privacy board is strongly recommended to verify local HIPAA privacy rule interpretation.
The Consent Process
HIPAA affects the number, length, and complexity of the forms in the participant consent process, which can be a deterrent to the recruitment of potential participants (Heiney et al., 2006; Ness, 2005; Steinke, 2004) . If the researcher is part of a covered or hybrid entity and is collecting PHI, he or she then faces three aspects to the consent process: provision of a copy of the institution's notice of privacy practices (NPP), obtaining informed consent, and obtaining a HIPAA authorization. Each institution has its own NPP, which informs patients as well as research participants about the institution's privacy practices and responsibilities under the law, the uses and disclosures of PHI, the participants' rights and how to exercise them, and the process for participants to gain access to their records. The researcher should obtain written acknowledgment that the participant received the NPP. At our institution, the written acknowledgment that the participant has received a copy of the NPP is part of the HIPAA authorization form.
Although HIPAA regulations require the authorization form and NPP to be "written in plain language" (U.S. Department of Health and Human Services, 2004, p. 12), recent research indicates that HIPAA authorization forms and NPP from top-ranked health care institutions do not meet that criterion. HIPAA authorization forms are written above the eighth-grade reading level and are similar in complexity to that found in "corporate annual reports, legal contracts, and the professional medical literature" (Breese, Burman, Rietmeijer, & Lezotte, 2004, p. 898) . The NPP forms are quite long (about 6 pages); they use a small font size (less than or equal to 10-point font); and they contain difficult language (reading levels between the 11th and the 13th grade; Breese & Burman, 2005) .
Although the researcher does not have control over the legal jargon and the overall length of the HIPAA authorization template utilized by his or her institution, there are mechanisms by which he or she can minimize participant burden during the consent process. Before submitting the HIPAA authorization form to the IRB or privacy board, the researcher needs to anticipate two things: all possible types of PHI needed for the study and all possible uses and disclosures of PHI. The researcher should use descriptive categories of PHI to be collected (e.g., blood tests rather than liver function tests) and generic titles of persons to whom the PHI might be used by or disclosed (e.g., graduate students or co-investigators rather than a specific individual). In the event of protocol or personnel changes, these proactive strategies will benefit both the researcher and the participants. The researcher will not have to submit an amended HIPAA authorization to the IRB or privacy board, and the participants will not have to read and sign an amended authorization form.
During the initial contact with the participant, it is critical for the researcher to explain all the study details, using simple lay language. When explaining the required forms to the participant, the researcher needs to present each document separately. The researcher can offer to read the documents to the participant. This allows participants with limited vision or low reading levels an opportunity to understand the forms without the embarrassment of having to admit to a disability. For medically frail participants, reading the forms aloud reduces the physical and mental effort required by the participant. The researcher must ask the participant if he or she understands what is involved in the study or has any questions or concerns before signing any forms. If these strategies are utilized, participants will be well informed and less likely to feel overwhelmed by the consent process and the HIPAA-required documentation.
Streamlining the consent and HIPAA document process can be challenging when the researcher is employed at one institution or covered entity (e.g., a local university) but will recruit participants or collect data at another institution or covered entity (e.g., a community hospital). Although reciprocal IRB approval is possible, many institutions require researchers to submit an IRB application to each institution during the initial implementation of HIPAA (Heiney et al., 2006; Lydon-Rochelle & Holt, 2004) , thus, increasing administrative burden. With advanced planning and clear communication between the researcher and the compliance officer at each institution, participant burden and administrative time can be minimized. To facilitate the process, the researcher needs to discuss the planned project with the compliance officer at each institution before submitting an IRB application. One IRB should agree to rely on the other institution's IRB approval and its consent and HIPAA documents. Obtaining reciprocal IRB approval not only decreases administrative burden but also ensures that the participant will be required to read and sign the consent and HIPAA documents from only one institution, thus minimizing participant burden during the consent process.
Long Term Follow-Up of Participants
For longitudinal or time series studies, it is essential for the researcher to be able to follow up with the participants. Retention of participants is known to be enhanced by utilizing appointment reminders (Villarruel et al., 2006) ; however, the researcher must be cognizant of participant privacy. Postcard reminders are discouraged under HIPAA because a participant's medical diagnosis may be inferred by anyone seeing the postcard (by virtue of the study logo or the researcher's or clinic's name). Mail reminders should be sent in an envelope, and the return address should not include the name of the study (e.g., the Breast Cancer Research Group). Care should be taken to make sure that the mail reminder does not look like a hospital bill; otherwise, the participant may delay opening it (Heiney et al., 2006) . If reminder telephone calls are utilized, PHI should not be revealed on answering machines or to family members answering the telephone. A generic message such as, "This is Dr. Jane Doe calling to remind you of your appointment on [date and time]. If you have any questions or need to reschedule, please call my office at [phone number]." Utilizing a mail reminder several days in advance, followed by a telephone reminder 24 to 48 hr in advance of a follow-up appointment, has been shown to be an effective strategy for retention of participants (Loftin et al., 2005; Villarruel et al.) . In the computer age, e-mail has become another option for appointment reminders. One must be cognizant that some older adults are not computer savvy and that some minorities may not have e-mail access (Lenhart et al., 2004) ; in which case, other strategies will need to be utilized.
Reimbursement of participants is a well-known strategy for their retention. The processes by which participants are reimbursed need to be consistent with participant privacy. The standard participant reimbursement process involves the university's accounting department sending a check to the participant's home. This reimbursement process can be problematic if the participant perceives that the disease being studied may have negative social or economic consequences (e.g., HIV, alcoholism, breast cancer). For example, in a small college town where the university is the largest employer in the area, participants may be concerned that personnel in the accounting department will know that they have been treated for a particular disease, by virtue of processing their reimbursement paperwork. To solve this dilemma, many researchers at our institution have established a personal research checking account for their studies, using a university-approved expense advance process. Alternatively, other researchers have bypassed this potential problem by reimbursing participants with gift cards, books of stamps, and other monetary equivalents (Loftin et al., 2005) .
Recruitment for Future Studies
Depending on the type of research performed, it is possible to utilize participants from previous studies in future studies. If the researcher did not have a HIPAA authorization to collect contact information during a study (e.g., address, e-mail address, telephone number), then he or she may not be able to contact previous participants directly for future studies without additional IRB or privacy board approval. If the researcher plans ahead, there are HIPAA-compliant strategies to assist with recruitment for future studies while minimizing administrative burden.
The creation of a recruitment database is a useful strategy for nurse researchers who do not have a clinical practice and do not have an existing treatment relationship with their population of interest (Erlen, 2005) . A recruitment database or research registry contains individuals who are interested in participating in future studies (Schwartz, Brecher, Whyte, & Klein, 2005) . A recruitment database is different from a clinical registry, which many health care providers keep and which contains all the patients' contact information and PHI. During our recent National Institute of Nursing Research-funded study testing the effects of position and compression bandaging in venous ulcer participants, we established an IRB-approved recruitment database. Our database is set up as two separate password-protected electronic database files. The first file is the participant contact file, which contains the following information: participant's name, home telephone, work telephone, cell phone number, mailing address, e-mail address, and preferred mode of contact. Each participant is given a coded ID number. The ID number in the participant contact file is identical to the corresponding entry in the participant history file. The participant history file contains minimal PHI, such as date of birth, gender, healthy control (yes/no), venous ulcer participant (yes/no), other microvascular disease (yes/no), and taking exclusion criteria medications (yes/no). A limited number of research staff have access to the database, and those who do must sign a privacy statement agreeing not to use the information for any other purposes. For future studies, the investigator can search the participant history file, identify potential participants, and write down their ID numbers. Then, the investigator can obtain the relevant contact information from the participant contact file and can contact the participant to ascertain interest in the new study.
We started our recruitment database after we had already completed several preliminary studies. To take advantage of our previous work, we obtained approval from our IRB to contact our previous participants and obtain consent (using waiver of documentation of consent procedures) to add previous participants to the database. Any participants who fail our telephone screening in our current venous ulcer study are offered the opportunity to be in our recruitment database for future studies. This is helpful for participants who are disappointed at not qualifying for the study. In all our current consents, we have a question (that the participant must initial beside the yes or no) asking if the participant is willing to be contacted for future studies. Participants indicating a yes response are added to the recruitment database.
Training of Research Staff
New research staff members require extensive training specific to the study protocol and procedures. The HIPAA privacy rule has added extra requirements for the training of new research staff and students. HIPAA privacy and human participants compliance training is required of all research team members, including staff and students. This training is time intensive and can be overwhelming, especially for undergraduate or graduate students with little exposure to research. Some recruitment sites (e.g., Veterans Administration hospitals) may require additional HIPAA privacy, good clinical practices, and cybersecurity training before staff and students can have any direct contact with participants, their data, and their medical records. If a student is doing an independent study with the research group, a lot of time can be spent completing the compliance training. We try to (a) arrange an independent study the semester before it is conducted; (b) include compliance training as part of the course objectives, content, and evaluation process; and (c) ask the student to complete the training in advance. This allows us to submit an amendment to add the student to our research team before the semester starts so that the student can assist immediately with participant recruitment, screening, and data entry activities. We have found that students benefit from the research experience and that this system helps us proceed with participant recruitment and retention activities with minimal interference.
Because IRB procedures and interpretation of HIPAA regulations continue to evolve (Connor, Smaldone, Bratts, & Stone, 2003; Erlen, 2005) , annual training updates are necessary to ensure compliance by researchers, their staff, and students. If co-investigators or research staff members do not complete their training updates on time, processing of IRB amendments or continuing research reviews may be delayed. At our institution, all IRB submissions are electronic, and the researcher is unable to submit any form if one research team member has expired compliance training. Such delays can be prevented by developing a system to track the training date of each research team member and by sending e-mail reminders before the training expires. Although these proactive measures prevent undue delays, they increase the administrative duties required of the researcher.
In conclusion, the HIPAA privacy rule was designed to protect the privacy of the individual's PHI. Although participant recruitment and retention have undoubtedly been affected by the HIPAA privacy rule, careful consideration of the regulations and prior planning can facilitate rather than hinder recruitment and retention efforts. Preparatory research reviews are helpful in determining study feasibility and sample populations. A HIPAA waiver of authorization may be needed to allow for prescreening over the telephone, and careful preparation of HIPAA authorization forms can prevent the need for amendments. The development of a recruitment database can facilitate recruitment for future studies. More than ever before, researchers will find it useful to work closely with health care providers to ensure continued access to potential research participants (Gunn et al., 2004; Loftin et al., 2005) . Establishing systematic procedures and records of HIPAA-compliance training and renewals will prevent unnecessary delays when studies are amended and renewed. Researchers and staff members who are knowledgeable of HIPAA regulations will experience fewer delays in the initiation of study protocols and will be better prepared to recruit and retain participants for their studies. Utilizing multiple methods of recruitment can reduce accrual time and create a more generalizable sample. Even with thorough preparation, researchers and funding agencies need to recognize that recruitment of participants for prospective clinical research studies in the post-HIPAA era requires additional time, effort, and personnel dollars (Loftin et al.; Lydon-Rochelle & Holt, 2004; Wolf & Bennett, 2006) . Grant timelines and personnel budgets need to be adjusted accordingly.
